Cannabis is increasingly used for chronic pain, sleep problems, nausea, anxiety, and other symptoms that may also become troublesome during recovery from surgery. That overlap naturally raises a question for patients who already use marijuana or CBD: can cannabis help after an operation, or could it interfere with recovery? The answer is more complicated than cannabis simply being another pain reliever. Surgery creates a unique medical situation involving anesthesia, prescription pain medicines, inflammation, wound healing, bleeding risk, respiratory function, and sometimes anticoagulant drugs. Cannabis can potentially influence several of these systems at the same time.
Current clinical guidance therefore treats cannabis as an important part of a patient’s perioperative medication history. The American Society of Regional Anesthesia and Pain Medicine recommends that surgical patients be screened for cannabinoid use, including the type of product, route of administration, frequency, amount, and timing of the most recent use. The guidelines also emphasize that regular cannabis users may experience greater postoperative pain and nausea and may require more pain medication than nonusers. Meanwhile, the U.S. Food and Drug Administration has not approved the cannabis plant or ordinary dispensary cannabis products as treatments for postoperative pain or surgical recovery.
Cannabis and Pain After Surgery
Cannabis has legitimate biological mechanisms that make its use for pain seem plausible. THC activates cannabinoid receptors involved in pain perception, while CBD and other cannabinoids interact with inflammatory, neurological, and signaling pathways that may influence discomfort. Federal health information from the National Center for Complementary and Integrative Health notes that cannabis and cannabinoids may provide a small benefit for some forms of chronic pain, particularly neuropathic pain. Acute surgical pain, however, is a different clinical problem. Incisions, tissue injury, inflammation, muscle spasm, bone injury, and nerve irritation can produce intense short-term pain that has not been studied nearly as thoroughly with cannabis.
In fact, some of the strongest surgical data point in the opposite direction from what many patients expect. A University of Michigan study involving 11,314 surgical patients across 69 hospitals found that people who used cannabis to treat pain after surgery were more likely to report moderate-to-severe surgical-site pain one week and one month later. After adjustment, cannabis users also consumed about one additional opioid pill, although researchers considered that difference clinically small. Cannabis users were also less likely to report high satisfaction and the best quality-of-life scores after surgery. Because this was observational research, it cannot prove cannabis caused worse pain; people experiencing more difficult pain may simply have been more likely to turn to cannabis. Nevertheless, the findings do not support the assumption that postoperative cannabis reliably reduces pain or eliminates the need for conventional analgesics.
Does Cannabis Reduce the Need for Opioids?
One of the most attractive arguments for postoperative cannabis is the possibility that cannabinoids could reduce opioid requirements. Laboratory and animal experiments have sometimes found synergistic effects between cannabinoids and opioids, creating the theoretical possibility that smaller opioid doses might provide adequate pain relief when cannabinoids are added. Human evidence has been considerably less convincing. NCCIH reports that higher-quality clinical studies examining cannabinoids alongside opioids have not demonstrated a reliable reduction in opioid use.
A large Cleveland Clinic analysis provides another reason for caution. Researchers studied more than 34,000 adults undergoing elective surgery, including 1,683 who had used cannabis during the 30 days before their operation. Preoperative cannabis use was associated with approximately 30% greater opioid consumption during the first 24 hours after surgery, along with higher postoperative pain scores. A 2026 study from researchers affiliated with the University of California system likewise found that patients with cannabis use disorder undergoing surgical repair of hand fractures had substantially greater postoperative use of opioids and other analgesics.
These studies do not mean cannabis inevitably worsens surgical pain. Frequent cannabis users may differ from nonusers in underlying pain disorders, opioid exposure, anxiety, sleep problems, or pain sensitivity. A prospective University of Michigan study found that cannabis-using surgical patients entered surgery with worse pain, greater functional impairment, poorer sleep, and greater opioid and benzodiazepine use than nonusers. Six months later, however, their overall surgical outcomes were similar. The important point is that cannabis should not automatically be viewed as an opioid substitute after surgery.
Cannabis, Inflammation and Surgical Wound Healing
The relationship between cannabinoids and healing is surprisingly complex. Cannabinoid receptors participate in inflammatory signaling, immune activity, skin biology, blood-vessel formation, and other processes involved in tissue repair. A 2024 review led by researchers at the University of Oklahoma Health Sciences Center found laboratory and animal evidence suggesting that certain cannabinoids—particularly when applied topically—may promote aspects of cutaneous wound healing. Yet the authors found only a small number of human studies, many involving case reports or observational evidence, and concluded that substantially more clinical research is needed before cannabinoids can be considered established wound treatments.
Systemic cannabis use after surgery should not be confused with experimental topical cannabinoid therapy. A broad surgical review found the evidence surrounding cannabis and wound healing to be conflicting and generally low quality. Recent observational studies demonstrate the uncertainty. A 2024 Loma Linda University and University of California San Diego orthopedic study involving 4,802 fracture-surgery patients found that current marijuana smoking was not independently associated with surgical-site infection. Tobacco smoking and diabetes were significant risk factors instead.
Other newer research has found associations with poorer wound outcomes among patients with cannabis use disorder. A 2026 University of Rochester study of hand and wrist procedures found that patients diagnosed with cannabis dependence had higher odds of superficial wound complications, infections, and return to surgery for deep infection. Another 2026 study of knee arthroscopy similarly reported higher rates of surgical-site infection and wound complications among patients with cannabis use disorder. Because these are observational database studies, they cannot establish that cannabis itself caused the complications; heavy cannabis use can overlap with tobacco exposure, medical comorbidities, socioeconomic differences, and other risk factors. The most scientifically accurate conclusion is therefore that human evidence about cannabis and surgical healing remains unsettled, with heavier or disordered use potentially representing a higher-risk clinical population.
Smoking or Vaping Cannabis During Surgical Recovery
Even if cannabinoids themselves eventually prove useful for certain forms of postoperative pain, smoking cannabis introduces a separate set of concerns. The American College of Surgeons notes that marijuana smoke can irritate the lungs and airways, contributing to coughing, wheezing, bronchial irritation, and other respiratory problems relevant to surgical patients. Cannabis also affects heart rate and blood pressure, factors that anesthesiologists and surgeons consider during the perioperative period.
Coughing is particularly undesirable after some operations because it suddenly increases pressure through the chest and abdomen and can place mechanical stress on new incisions. The American Society of Anesthesiologists advises that smoking cannabis after surgery can irritate the airway and provoke coughing, potentially stressing incisions, increasing blood pressure, or contributing to bleeding. The risk depends heavily on the procedure: coughing may be especially problematic after abdominal, chest, hernia, facial, vascular, or other operations in which tissues have been recently repaired.
Vaping eliminates combustion but does not make inhalation automatically appropriate during recovery. Cannabis aerosols can still irritate the respiratory tract, and THC can still produce cardiovascular and cognitive effects. Edibles avoid airway irritation but introduce their own disadvantages, including slower onset, longer duration, variable absorption, and the possibility of unexpectedly strong intoxication. NIH-supported research from Johns Hopkins University found that high-dose oral CBD given with THC increased THC exposure and produced stronger sedation, anxiety, memory impairment, and cardiovascular effects than the same THC dose alone.
Cannabis and Postoperative Medication Interactions
Medication interactions are one of the strongest reasons not to restart cannabis automatically after leaving the hospital. Surgical patients may temporarily receive opioids, benzodiazepines, muscle relaxants, sleep medications, gabapentin or pregabalin, antihistamines, anti-nausea medicines, and other drugs capable of producing sedation or dizziness. THC can impair attention, coordination, reaction time, and judgment. CBD can also cause sleepiness. Combining cannabis with other sedating drugs may therefore produce greater impairment than either substance alone. The American Society of Anesthesiologists specifically cautions about marijuana use with opioids and other sedating medications during postoperative recovery.
The FDA also warns that CBD can interact with prescription medications by changing how drugs are metabolized. Information derived from the FDA-approved CBD medicine Epidiolex demonstrates that CBD can inhibit several liver enzymes involved in drug metabolism. FDA educational material identifies clinically relevant concerns involving CYP enzymes such as CYP2C9 and CYP2C19; documented examples include interactions involving warfarin and the benzodiazepine clobazam. The FDA further warns that combining CBD with medications that slow brain activity can increase sedation and drowsiness.
This issue can be especially important following orthopedic, vascular, cardiac, and other operations in which anticoagulants are used to prevent blood clots. Warfarin has a narrow therapeutic range, and changes in its blood concentration can alter bleeding or clotting risk. Evidence surrounding cannabis interactions with newer anticoagulants is less certain, but theoretical metabolic interactions exist for several drugs. Patients should therefore not assume that a CBD product is interaction-free simply because it does not produce a noticeable high. NCCIH emphasizes that herb-drug interaction data are often incomplete and that special caution is appropriate with narrow-therapeutic-index drugs such as warfarin.
CBD has another postoperative consideration: the liver. FDA safety assessments have demonstrated that sufficiently high CBD exposure can cause elevations in liver enzymes and, in some cases, liver injury. That becomes more relevant when a patient is simultaneously taking medications processed by the liver. Commercial CBD oils also vary considerably in cannabinoid concentration and purity, meaning evidence obtained from pharmaceutical-grade CBD cannot simply be extrapolated to every retail product.
How Soon After Surgery Can You Use Cannabis?
There is currently no universal evidence-based number of hours or days after surgery when cannabis becomes safe to resume. The appropriate interval depends on the operation, type of anesthesia, respiratory status, medications being taken, cardiovascular history, usual cannabis exposure, and method of consumption. The American Society of Anesthesiologists notes that research has not established a single safe time to resume marijuana after surgery. It also advises against marijuana use while patients remain affected by anesthetic medications, which can impair judgment for roughly 24 hours after many procedures.
Someone recovering from a small procedure under local anesthesia may face a very different risk profile from a patient recovering from abdominal surgery, spinal fusion, joint replacement, heart surgery, or an operation requiring significant opioid medication. Smoking may remain inappropriate long after the anesthetic itself has worn off if coughing could interfere with the surgical repair. Similarly, a patient taking anticoagulants or sedating medicines may need to avoid or modify cannabinoid use for longer. For these reasons, the safest approach is to ask the surgeon or anesthesiologist specifically about THC, CBD, the intended route of administration, and the medications currently being taken, rather than simply asking whether “marijuana” is permitted.
Frequent Cannabis Users and Withdrawal After Surgery
Patients who use cannabis every day or almost every day present another issue: abruptly stopping can produce withdrawal symptoms. These may include irritability, insomnia, anxiety, decreased appetite, restlessness, mood changes, sweating, headache, and gastrointestinal symptoms. Some of these complaints can resemble normal postoperative symptoms, making them easy to overlook. ASRA’s perioperative guidelines specifically address cannabis withdrawal as part of postoperative management, while the American College of Surgeons advises patients who have difficulty stopping cannabis to discuss the problem with their surgical team.
Regular users may also develop tolerance to some cannabis effects while simultaneously having a different response to anesthesia and postoperative pain treatment. This is one reason clinicians need accurate information about frequency and dose. The purpose of disclosing cannabis use is not to judge the patient; it allows the anesthesia and surgical teams to anticipate pain-control requirements, possible withdrawal, cardiovascular or respiratory effects, and drug interactions. ASRA therefore recommends universal preoperative screening rather than screening only patients thought to have problematic cannabis use.
Final Thoughts on Cannabis After Surgery
Cannabis may eventually have a defined role in certain forms of postoperative pain management, and researchers are actively testing that possibility. Michigan Medicine and Henry Ford Health, for example, launched a federally funded clinical trial examining whether pharmaceutical-quality CBD around knee-replacement surgery can reduce opioid requirements. The fact that such a major randomized trial is still needed illustrates how many important questions remain unanswered.
For now, the evidence does not support treating marijuana or over-the-counter CBD as routine postoperative pain medicine. Regular cannabis users often report more—not less—pain after surgery, and studies have not consistently demonstrated meaningful opioid-sparing effects. Evidence concerning wound healing is mixed, smoking can create respiratory and mechanical problems during recovery, and CBD and THC can interact with medications commonly used after surgery. The practical takeaway is not that every surgical patient must permanently avoid cannabis. It is that when and how cannabis is resumed should be considered part of the postoperative medication plan, especially when opioids, sedatives, anticoagulants, significant wounds, or major surgery are involved.
Patients who already use medical cannabis should tell their surgeon and anesthesiologist exactly what they use, including THC or CBD content, dose, frequency, route, and last use. Those details allow the clinical team to balance potential symptom relief against anesthesia effects, medication interactions, bleeding risk, respiratory concerns, and the needs of the healing surgical site. As cannabis becomes increasingly common, open communication and individualized perioperative planning remain more evidence-based than assuming that cannabis is either universally dangerous or universally beneficial after surgery.
